-
Geneticin Workflows for Stable Cancer Cell Models
2026-08-31
Geneticin, also called G418 Sulfate, converts successful gene delivery into a selectable, expandable cell population for mechanistic cancer assays. This guide connects dependable G418 selection with CLK2–BRCA1 platinum-resistance studies and a distinct, context-dependent Dengue virus inhibition workflow.
-
AY 9944 Dihydrochloride: DHCR7 Research Guide
2026-08-31
AY 9944 dihydrochloride is a selective DHCR7 inhibitor that blocks the conversion of 7-dehydrocholesterol to cholesterol. Product data report a 13 nM IC50 against recombinant human DHCR7, while a 2026 grass-carp study provides in vivo genetic evidence connecting dhcr7 disruption with stronger antiviral resistance.
-
JNJ-10198409: A PDGF Signaling Assay Framework
2026-08-30
JNJ-10198409 is a potent platelet-derived growth factor receptor inhibitor for dissecting PDGF-driven proliferation, angiogenesis, and fibrosis. This article develops a time-resolved assay strategy informed by recent work on dynamic host-kinase signaling, rather than repeating a conventional product overview.
-
Dronedarone (Multaq): Translational AF Strategy
2026-08-29
Dronedarone (Multaq) offers translational researchers a valuable probe for separating broad antiarrhythmic pharmacology from atrial-selective KCa2 channel hypotheses. This article connects mechanistic evidence, exposure-aware assay design, CYP3A4 and CYP2D6 considerations, formulation strategy, and competitive positioning for atrial fibrillation and atrial flutter research.
-
AP-2α Reverses TMZ Resistance in Recurrent GBM
2026-08-28
The reference study identifies AP-2α as an upstream transcriptional suppressor of MGMT in recurrent glioblastoma and shows that restoring AP-2α activity improves temozolomide-associated DNA damage. By connecting retinoic acid–RAR/RXR signaling with MGMT regulation, the work provides a mechanistic framework for overcoming TMZ resistance rather than treating MGMT as an isolated biomarker.
-
Linoleic Acid: Assays, Workflows & QC
2026-08-28
Linoleic Acid, or C18:2(9Z,12Z), enables controlled studies of membrane behavior, oxidative injury, erythrocyte damage, and epithelial migration. This practical guide connects fresh, solvent-based handling with the fatty-acid signaling insights revealed in a recent fasting and tumorigenesis study.
-
Dovitinib (TKI-258) for Mechanism-Driven Assays
2026-08-27
Dovitinib enables a practical perturbation workflow for connecting broad RTK signaling with proliferation, apoptosis, and metastatic phenotypes in cancer models. This article translates the circRHOBTB3–NONO–MAOA findings in prostate cancer into assay choices while clearly separating established product biology from exploratory applications.
-
Oxaliplatin and the Logic of Tumor Heterogeneity
2026-08-27
Oxaliplatin is more than a cytotoxic benchmark: it is a translational probe for studying DNA damage, apoptosis, metastatic evolution, and therapeutic heterogeneity in colorectal cancer models.
-
LMO2–LDB1 Complex Drives AML Cell Maintenance
2026-08-26
The 2023 Cell Death and Disease study identifies LDB1 as a functional partner and dependency of LMO2 in acute myeloid leukemia (AML). By combining perturbation assays, protein-interaction analysis, transcriptomics, ChIP-seq, and rescue experiments, the authors connect the LMO2/LDB1 complex with AML cell proliferation, survival, and apoptosis-related gene regulation.
-
How Nuclear ERK Shapes Translation in Cardiomyocytes
2026-08-26
Uchida and colleagues identify a compartment-specific mechanism in which nuclear ERK phosphorylates 4EBP1 at Ser64 to reposition translation toward the cardiomyocyte interior during concentric hypertrophy. The study distinguishes mTORC1 control of overall translation from ERK-dependent spatial organization, offering a framework for interpreting how kinase localization can shape cell architecture.
-
PTGER4–HDAC Signaling in Rectal Epithelium
2026-08-25
Anbazhagan et al. identify a stromal–epithelial signaling mechanism in which mesenchymal stromal cell-derived PGE2 activates PTGER4 and alters class IIa HDAC phosphorylation in rectal organoids. The pathway increases SPINK4 mRNA and extracellular SPINK4, providing a mechanistic framework for epithelial repair and for interpreting PTGER4 activity in inflammatory bowel disease.
-
From Epitope Maps to Human IgG Readouts
2026-08-25
How M1R/B6R antibody discovery informs translational assay design, and where a Cy3-conjugated anti-human IgG secondary antibody can strengthen the evidence chain without overstating antiviral validation.
-
Nifedipine: Calcium Assay Design Beyond PXR Models
2026-08-24
Nifedipine (BAY-a-1040) is more than an L-type calcium channel blocker: it is a useful perturbation tool for separating calcium-dependent phenotypes from transcriptional and metabolic adaptation. This article connects rigorous calcium, viability, iron-transport, and pathogen assays with lessons from a recent PXR rat study.
-
Open-Platform DLP for 96-Well Hydrogel Printing
2026-08-24
Mathis and colleagues introduce a low-cost, open-platform digital light printer that fabricates patterned 2D hydrogels and locally activates photocaged DNA in 96-well formats. Its LabVIEW control, planar correction, wavelength flexibility, and vessel compatibility address reproducibility and customization constraints in high-throughput biomaterials workflows.
-
Acetylcysteine for Redox Assay Design
2026-08-23
Learn how Acetylcysteine and N-acetyl-L-cysteine can be deployed as controllable redox perturbation tools in cell, organoid, hepatic, respiratory, and neurodegeneration workflows. The article also translates a photothermal–immune nanoplatform study into practical assay controls without implying that NAC was part of the original formulation.